No Data
NRx Pharmaceuticals (NASDAQ: NRXP) Announces Participation in the NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference December 3-4, 2024
Express News | HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $19 Price Target
NRX Pharmaceuticals Analyst Ratings
Express News | NRX Pharmaceuticals (Nasdaq:Nrxp) Announces Publication of Paper Entitled "Quality Assurance of Depression Ratings in Psychiatric Clinical Trials"
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Publication of Paper Entitled "Quality Assurance of Depression Ratings in Psychiatric Clinical Trials"
NRX Pharmaceuticals Strengthens Leadership With New CFO Appointment